Dr. Steen Ottosen is a physician with a medical degree from the University of Southern Denmark and clinical experience from general surgery as well as family medicine and specialization in public health medicine from the University of Oslo, Norway. He has 20 years of experience in drug safety, medical and regulatory affairs and quality management. He is the founder of the drug safety consultancy company Steen Ottosen ApS with consultants and clients in the US and Europe. Previously he has been leading a number of drug safety organizations as well as serving as Qualified Person for Pharmacovigilance around the world including companies like La Jolla Pharmaceutical, Arena Pharmaceuticals, Amgen, PRA International, Pharmion, Genmab, and Lundbeck.

Open access literature databases for mandatory drug safety literature screening during clinical development and post-market – equal access to new science for pharmaceutical companies.

Dr. Ujwala Salvi is a Founder & Chief Executive Officer, at NUCLEON Therapeutics LLP, Mumbai (India). She has an MBA in Finance from the Indian Institute of Management (IIM), Kolkata & Doctorate in Applied Biology from Mumbai University, has over 15 years of experience across the Global Pharmaceutical/CRO, Tier I Medical Devices and BPO industry.

Process Optimization and Role of Artificial Intelligence in Global Pharmacovigilance.

Dr. Robert L. Barkin is Professor of Anesthesiology, Pharmacology, and Family Medicine at Rush University Medical College in Chicago, Illinois. He is also a clinical pharmacologist in a collaborative practice with 5 physician pain specialists at the NorthShore University Health System Department of Anesthesiology Pain Center’s of Skokie and Evanston Hospitals in Illinois. Dr. Barkin’s extensive daily practice is both outpatient and in-patient. Dr. Barkin designs patient specific pharmacotherpeutic treatment plans.

Pain – Acute and chronic, Postoperative pain, fibromyalgia, migraine headache, Neuropathic & nociceptive pain, Psychopharmacology

Dr. Ashok Srivastava is Chief Executive Officer and Chief Medical Officer of Cure Pharmaceuticals, and ClinFomatrix Oncology CRO, He was founder, Chief Executive Officer and Chief Medical Officer of CareBeyond - A Radiation Therapy Cancer Center, New Jersey. USA. He has more than 15 years of experience in drug development, medical affairs and commercialization of cancer drugs including radiopharmaceutical and supportive care; Phase 1 – 4, and marketing commercialization of Hematology, Oncology and radio-immuno-oncology drugs in USA, EU and Japan.

Mircea Ciuca, MD is currently Global Head of Medical & Clinical Drug Safety at Vifor Pharma in Switzerland. He is leading a team of scientists and physicians involved in all aspects of pharmacovigilance, in both development and post-marketing settings. Mr. Ciuca has about 13 years of experience in drug safety. Prior to join Vifor Pharma he held various positions (Deputy QPPV, Senior Pharmacovigilance Medical Manager, Drug Safety Advisor) at large pharmaceutical companies in The Netherlands, after successfully establishing and leading the medical- scientific department of a medium-size CRO in Rotterdam.

Clinical Drug Safety, clinical practice,Pharmacovigilance

Prof. Dr. Heyam Saad Ali, Ph-D –She is working in pharmaceutics department in Dubai Pharmacy College, UAE. Prof. contributed more than 70 articles to reputed international scientific journals and conferences, in different conventional, controlled and targeted drug delivery systems in pharmaceutical product development. She has been invited as speaker to numerous International conferences .Reviewer and member of editorial board of many international journals.

Dr Antonini received her M.D. from the University of Rome “La Sapienza” Magna Cum Laude, with Top Honors in all examinations. She has a PhD in Clinical Pharmacology. In more than 30 years of experience in Big Pharma /CRO Industry and Dr Antonini has played a key role in many successful programs of drug development, capitalizing on her scientific leadership and on-the-job experience in the designing, implementation and interpretation of clinical trials. Among Dr Antonini’ accomplishments are a substantial contribution to the clinical development of a number of products in the cardiovascular, internal medicine, metabolism, respiratory, oncology and neuroscience area. Dr Antonini has established valuable relationships and collaborations with many key scientific leaders in a number of therapeutic areas and this allowed her to build an innovative, strong partnership with Italian and International Academia in the field of Clinical Research. As a peer interlocutor of Academy members Dr Antonini has been invited to be Lecturer at Master in Clinical Research organized by several Universities. She authored several peer-reviewed articles and has been invited as speaker in International and National events in the areas of

Pharmaceutical Medicine, Methodology of clinical trials and Pharmacology, Clinical Research

Prof Mohamed Eddouks has received his PhD in University of Liege, Belgium during the period of 1990-1993. Currently, he/she is working as Professor in Moulay Ismail University. He has successfully completed her Administrative responsibilities as founding Dean of Polydisciplinary Faculty of Errachidia. His research has included antidiabetic and antihypertensive medicinal plants. Based on this research and fellowship training he has received several awards and honors, such as The first Prize of Scientific Research in 2008 by the Moroccan Association of Research and Development. He is serving as an editorial member of several reputed journals like Evidence-based Complementary and Alternative Medicine, International Journal of Pharmacy and Pharmaceutical Sciences, Asian Journal of Pharmaceutical and Clinical Research, Metabolic and Functional Research on Diabetes, Pharmacology and Pharmacy, Research Journal of Pharmacology, Pharmaceutical Regulatory Affairs…etc & expert Reviewers for journals like Journal of Cardiovascular Pharmacology, Journal of Pharmacy and Pharmacology, Journal of Food Biochemistry, Plant Foods for Human Nutrition, Diabetes Research and Clinical Investigation, Journal of Herbal Pharmacotherapy, Evidence Based Complementary and alternative Medicine, Journal of Herbs Spices and Medicinal Plants, Life Sciences, Biophysica Biochemica Acta, Phytotherapy Research, Journal of Ethnopharmacology and Journal of Medicinal Plants Research….etc. He has authored more than 70 research articles and 3 books. He is a member of American Diabetes Association, American Stroke Association, the Scientific Council for High Blood Pressure, Research and European Institute for the Ambulatory Study of Obesity and Diabetes.

Obesity, Diabetes, Pharmacology, Food Biochemistry

Prof. Sinerik Ayrapetyan has completed his Ph.D in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev. He is the head and coordinator of Research Council of Life Sciences International Postgraduate Educational Center and UNESCO Chair in Life Sciences in Yerevan, Armenia. His current research interest is “Intracellular Signalling System in Norm and Pathology”. On this subject he has published more than 7 international books and 115 papers in refereed journals. He is serving as a member of the board of associate editors for the journals: "Electromagnetic Biology and Medicine" "Journal of International Dental and Medical Research", “ISRN Biophysics” and member of editorial board of the journals: “Advances in Life Sciences", “Bioavailability and Bioequivalence”, “Applied Pharmacy”, “European Journal of Biophysics”, “Biochimica et Biophysica Acta”. He is a member of International Coordination Council of WHO and number of professional international societies

Metabolic regulation of excitable cell membrane function,neuroscience, intracellular signaling system in norm and pathology

Dr. Tirotta is a member of numerous professional societies and has served on a number of hospital committees, including the Heart Program Executive Committee. He previously served as the Co-Chair of the Miami Children’s Hospital Physician Hospital Organization. He is also responsible for giving numerous medical lectures nationally and internationally and is actively engaged in clinical research. He has been the Principal Investigator on a number of clinical drug/device trials, including on the ONQ Pain Buster, the muscle relaxant Zemuron, the procoagulant RiaSTAP, the Cardiotronic NICOM device and the ClearLine. He will also be the Principal Investiagator in Merck’s Sugammadex pediatric trial and Pacira Pharmaceuticals pediatric Exparel trial.

Pediatric Cardiac Surgery Patients, Clinical Anesthesia, clinical drug/device trials , Pharmaceuticals pediatric Exparel trial,

Richard H. Parrish II is Director and Chief Pharmacist at St. Christopher’s Hospital for Children in Philadelphia, Pennsylvania, USA and President and Executive Officer at Meds4Kids RESEARCH COLLABORATIVE, LTD, (M4KRC) a think-tank of concerned clinical pharmacists and pediatricians devoted to the creation of safer medication management systems designed for children and their families. All other authors are members of the Board of Advisors for M4KRC

Pediatric pharmacotherapy and Clinical Pharmacy.

EugeniaYiannakopoulou works as an Academic Teacher in the Department of Medical Laboratories of the Faculty of Health and Caring Professions, Technological Educational Institute of Athens (Athens University of Applied Sciences), Greece. Since 2015 she works as a Faculty Staff of the Master in Science Biomedical Methods and Technology in Diagnosis organized by the Department of Medical Laboratories Highest Technological Educational Institute of Athens. She is Director of her own private medical practice where she works as a consultant surgeon with special interest in Endocrine Surgery and Breast Surgery. Eugenia Yiannakopoulou graduated from the Medical School of National and Kapodistrian University of Athens. Postgraduate studies: MSc Minimally Invasive Surgery; MSc Medical Biology; MSc Biostatistics; PhD Pharmacology; University Diploma in Breast Diseases Medical School University of Strasbourg, France; University Diploma of Laparoscopic Surgery Medical School University of Strasbourg, France. University Diploma of Endocrine Surgery Medical School University Pierre et Marrie Currie Paris, University Diploma in Targeted Biotherapeis of Inflammatory and Autoimmune Diseases, Medical School University of Montpellier, University Diploma in Inflammatory Bowel Diseases Medical School University Pierre et Marie Currie Paris. She has completed postdoctoral research in Pharmacology. Eugenia Yiannakopoulou is Hellenic National Board certified in Surgery. She speaks English, German, Italian, French, Russian, Spanish, Portugues, Dutch. Eugenia Yiannakopoulou is member of the European Association of Endoscopic Surgery, of the European Society of Endocrine Surgeons, of the British Pharmacological Society, of the European Association of Clinical Pharmacology and Therapeutics, of the European Network for the study of Adrenal Tumors. Eugenia Yiannakopoulou is member of the Research Committee of the European Association of Endoscopic Surgery. She has authored 57 research papers published in international journals and 6 book chapters and has presented 60 papers at national and international conferences. She is a Reviewer of peer-reviewed journals including Surgical Endoscopy, British Journal of Surgery, European Journal of Pharmacology, Journal of Clinical Pharmacology, Pharmacotherapy, Annals of Pharmacotherapy, European Journal of Preventive Cardiology, Molecular Nutrition and Food Research. She is a member of the Editorial Board of a number of journals.

Pharmacology, Clinical Pharmacology, Pharmacotherapy, Annals of Pharmacotherapy

Toxicologist with more than 15 years working in the field of nonclinical toxicology and safety assessment. Experiences in Pharma Company and Contract Research Organization. Senior Toxicologist involved in Pharmacovigilance to support the efficacy, safety and well-use of medicines of our Company. Experience as Medical Adviser in dermatological area. Medical-Scientific support worldwide to the medicines of our Company. Study director, design, conduction and preparation of final reports of in vitro and in vivo toxicological studies in drug development, drug-candidate selection. Experience in toxicological data interpretation, preparation of nonclinical toxicology-safety report, reviews and summaries of safety of new drugs to support clinical studies.

Nonclinical Toxicology,Safety Assessment and Pharmacovigilance

Dr. Lopez-Ruiz has completed his Ph.D. from Valencia University and postdoctoral studies from CEU Cardinal Herrera Health Sciences Faculty. She obtained her doctorate in Medicine with the doctoral thesis on “Analysis of the use of medication in the paediatric population that visit accident and emergency department” with summa cum laude. She has achieved the qualification of “University Expert in Neonatology” from the Catholic University of Valencia and “Master’s Degree in Neonatology (from de SENeo -Neonatology Spanish Society-)”. She is Medicine Degree Coordinator in CEU Cardenal Herrera University since 2015. She is the director of the “Master’s degree in Neonatal Intensive care and Neonatal Nursing”. She has attended to International Congresses of Pediatrics as a keynote speaker and she has been part of the Organizing Committee member for the 12th International Conference on Pediatric Pathology and Laboratory Medicine, and she has published in reputed international journals.

Pediatrics, Neonatology, Human Anatomy, Pharmacology

Prof Mohamed Eddouks has received his PhD in University of Liege, Belgium during the period of 1990-1993. Currently, he/she is working as Professor in Moulay Ismail University. He has successfully completed her Administrative responsibilities as founding Dean of Polydisciplinary Faculty of Errachidia. His research has included antidiabetic and antihypertensive medicinal plants. Based on this research and fellowship training he has received several awards and honors, such as The first Prize of Scientific Research in 2008 by the Moroccan Association of Research and Development. He is serving as an editorial member of several reputed journals like Evidence-based Complementary and Alternative Medicine, International Journal of Pharmacy and Pharmaceutical Sciences, Asian Journal of Pharmaceutical and Clinical Research, Metabolic and Functional Research on Diabetes, Pharmacology and Pharmacy, Research Journal of Pharmacology, Pharmaceutical Regulatory Affairs…etc & expert Reviewers for journals like Journal of Cardiovascular Pharmacology, Journal of Pharmacy and Pharmacology, Journal of Food Biochemistry, Plant Foods for Human Nutrition, Diabetes Research and Clinical Investigation, Journal of Herbal Pharmacotherapy, Evidence Based Complementary and alternative Medicine, Journal of Herbs Spices and Medicinal Plants, Life Sciences, Biophysica Biochemica Acta, Phytotherapy Research, Journal of Ethnopharmacology and Journal of Medicinal Plants Research….etc. He has authored more than 70 research articles and 3 books. He is a member of American Diabetes Association, American Stroke Association, the Scientific Council for High Blood Pressure, Research and European Institute for the Ambulatory Study of Obesity and Diabetes.

Obesity, Diabetes, Pharmacology, Food Biochemistry